Characteristics of adverse drug reactions and risk management strategies for methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss: a clinical study of 1026 patients
The risk of ADRs from methylprednisolone sodium succinate is closely related to patients' underlying conditions and treatment regimens. A stratified warning system and optimized individualized treatment strategies are necessary.
Authors
- Shuangba He (ORCID: https://orcid.org/0000-0002-5171-8819)
- Wei Meng (ORCID: https://orcid.org/0000-0002-8689-0811)
- Jie Meng (ORCID: https://orcid.org/0000-0002-4485-4812)
- Shu Yan (ORCID: https://orcid.org/0000-0001-7689-9233)
- Ting Wu (ORCID: https://orcid.org/0000-0002-2384-1430)
- Yu Tang
Institutions
- Tongren Hospital (CN)
- Southeast University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-06-11
- DOI
- https://doi.org/10.3389/fmed.2025.1589531
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- Nanjing Medical Science and Technique Development Foundation